282 related articles for article (PubMed ID: 18767046)
1. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
[TBL] [Abstract][Full Text] [Related]
2. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
3. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
[TBL] [Abstract][Full Text] [Related]
4. Risk of cervical cancer after a negative Pap smear.
Viikki M; Pukkala E; Hakama M
J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
Budge M; Halford J; Haran M; Mein J; Wright G
Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
[TBL] [Abstract][Full Text] [Related]
6. Incidence of cervical cancer following negative smear. A cohort study from Maribo County, Denmark.
Lynge E; Poll P
Am J Epidemiol; 1986 Sep; 124(3):345-52. PubMed ID: 3740035
[TBL] [Abstract][Full Text] [Related]
7. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
Sirovich BE; Gottlieb DJ; Fisher ES
J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
[TBL] [Abstract][Full Text] [Related]
8. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
9. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
Eltabbakh GH; Eltabbakh GD
J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
[TBL] [Abstract][Full Text] [Related]
10. Risk of cervical cancer following negative smears in Maribo County, Denmark, 1966-1982.
Lynge E; Poll P
IARC Sci Publ; 1986; (76):69-86. PubMed ID: 3570417
[TBL] [Abstract][Full Text] [Related]
11. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
12. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
13. Pap test--with or without vaginal smear?
Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
[TBL] [Abstract][Full Text] [Related]
14. Incidence of cytological abnormalities within 24 months of a normal cervical smear in Soweto, South Africa.
Adam Y; McIntyre JA; De Bruyn G
S Afr Med J; 2012 Nov; 103(1):34-9. PubMed ID: 23237122
[TBL] [Abstract][Full Text] [Related]
15. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
16. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
18. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands.
Rebolj M; van Ballegooijen M; Berkers LM; Habbema D
Int J Cancer; 2007 Feb; 120(4):806-12. PubMed ID: 17131311
[TBL] [Abstract][Full Text] [Related]
19. [Follow up after an abnormal pap smear: time interval acceptable, nature of follow up leaves room for improvement].
Geertsen M; Bais AG; Beerman H; Helmerhorst TJ
Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2430-4. PubMed ID: 14694554
[TBL] [Abstract][Full Text] [Related]
20. Abnormal Pap smear follow-up in a high-risk population.
Engelstad LP; Stewart SL; Nguyen BH; Bedeian KL; Rubin MM; Pasick RJ; Hiatt RA
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1015-20. PubMed ID: 11588126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
